Form 8-K - Current report:
SEC Accession No. 0001104659-24-116790
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:24
Documents
13
Period of Report
2024-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428196d1_8k.htm   iXBRL 8-K 23982
  Complete submission text file 0001104659-24-116790.txt   196765

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pahc-20241107.xsd EX-101.SCH 3003
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20241107_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20241107_pre.xml EX-101.PRE 22351
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2428196d1_8k_htm.xml XML 3751
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 241448373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)